The incidence of biliary obstruction due to cancer in the population of Bangkok may be limited
Conditions
Interventions
Combination of endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography-guided biliary drainage in unresectable malignant hilar biliary obstruction ,Endoscopic transpapillary bila
Treatment,Treatment
CERES,BILAT
Sponsors
Excellence Center of GI Endoscopy, King Chulalongkorn Memorial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Patients with unresectable cancer causing biliary obstruction who have: -Bismuth stage 3 and 4 biliary obstruction. -Left intrahepatic dilatation. -More than 80% viable liver volume. -No ascites. -Aged 18-85 years. -An Eastern Cooperative Oncology Group (ECOG) Performance Status Scale level of 0-1. -An expected lifespan of more than 1 year.
Exclusion criteria
Exclusion criteria: 1.Patients with insufficiently stable vital signs to undergo endoscopic biliary procedures. 2.Patients with coagulation disorders, indicated by a platelet count less than 50,000/mm3 or an 3.International Normalized Ratio (INR) greater than 1.2, even if corrected with blood products or medications. 4.Pregnant women. 5.Patients who are unable to provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurrent biliary obstruction rate 6-month Bilirubin Test,success rates 6 months recurrence of biliary obstruction | — |
Secondary
| Measure | Time frame |
|---|---|
| success rates 6 months recurrence of biliary obstruction | — |
Countries
Thailand
Contacts
Public ContactPradermchai Kongkam
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed